Hourly Briefing | 2026-08-19 22:00 CST
The US Treasury raised its long-dated buyback cap to at least $4B, sending gold surging nearly 3% past $4,450 to its highest since June 5 while the dollar index broke below 99; Moderna and Merck reported success in a Phase 3 melanoma mRNA vaccine trial, with MRNA roughly doubling intraday to a $50B market cap; Marvell and Google expanded their chip partnership, widening dispersion across AI compute names.
π Market Snapshot
- Spot Gold XAUUSD: 4,460.53 (+2.92%), highest since June 5, intraday high 4,466; NY gold futures +3% above 4,500
- WTI Crude USOIL: 84.34 (roughly flat)
- Dollar Index DXY broke below 99, first time since June, -0.65% on the day
- US stocks opened: Dow +0.34% at 53,522, S&P 500 +0.43% at 7,725, Nasdaq +0.3%
- Long-end Treasury yields pulled back as the bond selloff eased
π₯ Key News This Hour
- [Treasury “rescue”] Announced raising the long-dated buyback cap to at least $4B in response to surging yields; gold spiked nearly $100 in a short burst
- [Vaccine milestone] Moderna and Merck reported success in a Phase 3 melanoma mRNA vaccine trial; MRNA roughly doubled intraday with a $50B market cap; Merck +10% to a record high, BioNTech +17.6%, Nasdaq biotech index +3.2%
- [Chip reshuffle] Marvell and Google expanded their chip development partnership, granting Google warrants for up to $12.2B of Marvell stock; MRVL +10.8%, Broadcom -2%
- [Precious metals surge] Spot gold +3% past $4,450, silver +3% above $65, platinum +3%; NYSE Arca gold miners index at highest since May; China Gold Association issued a statement responding to the US UFLPA entity list
- [Earnings & stocks] Estee Lauder +12% (full-year profit guidance beat); Target +5.4% to highest intraday since Oct 2024; Honeywell Aerospace +3.9% (Morgan Stanley upgrade to Overweight); Nebius -6% (plans $4.5B convertible bond)
π§ Situation Assessment
Gold is the dominant story this hour, driven by the higher buyback cap, the dollar breaking below 99, and safe-haven demand in tandem; momentum is strong near term but high-level volatility risk warrants caution.
The vaccine and biotech sector saw a milestone-level industrial advance, a substantive positive rather than mere speculation.
AI compute is being reshuffled again, with Google deepening ties with Marvell at Broadcom’s expense; individual names are diverging and rotation within the sector is evident.
On the macro side, long-end yields retreating from highs offers temporary relief, but supply pressure from government debt and data-center financing remains, and inflation worries have not fully faded.
β° Upcoming Key Data
The financial calendar client returned only 8/17 published data this week; future items were not fetched. By convention, watch tonight’s 22:30 CST US EIA crude inventories, and later this week Thursday’s jobless claims and existing home sales.